Homepage » Courses-Seminars » Neuropsychopharmacology

NEUROPSYCHOPHARMACOLOGY

Co-ordinators

Christina Dalla, Assistant Professor of Psychopharmacology, Department of Pharmacology, Medical School of Athens, National & Kapodistrian University of Athens

Nikolaos Kokras, Psychiatrist/Psychopharmacologist, Department of Pharmacology, Medical School of Athens, National & Kapodistrian University of Athens

T

Teaching hours and weekly schedule

This is a 2nd semester elective course of about 2.5 weeks that corresponds to 4 ECTs and 31 total hours of teaching including student presentations.

Description

This is an intensive 2.5-week course focused on neuropsychopharmacology that includes lectures from pharmacologists, clinicians, neuroscientists and other specialties. The course will also accommodate student’s presentations on specific neuropsychopharmacological issues, as well as written-exercises on pharmacological experimental design.

The lectures will focus on basic principles of pharmacology (such as pharmacokinetics and pharmacodynamics), information on drug design and discovery, treatment of neuropsychiatric disorders, as well as drug-induced changes in functioning of the nervous system. Additionally, the lecturers will give an overview of the techniques and models used for the study of neuropharmacology, as well as the basics of CNS clinical research, including regulations and statistical principles.

The goal is that students will become accustomed with neuropsychiatric treatment, modelling and research. Ultimately, they will be able to pose relevant neuropsychopharmacological questions and contribute to the design of preclinical and clinical studies. 

Course Overview

The course will include lectures on drug design/discovery, as well as principles of neuropsychopharmacology preclinical and clinical studies. Students will have the opportunity to present specific neuropsychopharmacological issues, as well as to perform written-exercises on pharmacological experimental design and analysis.

Most importantly, an interactive approach, with the use of poll-machines, will be used for the teaching of the neuropsychopharmacological basis, study and mechanism of action of:

•             Antipsychotics

•             Antidepressant drugs and mood stabilizers

•             Antiepileptics

•             Cognitive enhancers

•             Drugs of abuse

•             Antiparkinsonian drugs and drugs for the treatment of neurodegenerative diseases

•             Neuroimaging ligands

Skills & Learning Outcomes

Upon successful completion of this course, students will be able to:

 

1.            Understand basic pharmacological principles

2.            Know about most classes of neuropsychopharmacology drugs

3.            Know about adverse effects, drug interactions and genomics of CNS-acting drugs

4.            Identify new targets for CNS treatments and pose relevant questions

5.            Understand the methods used in preclinical and clinical neuropsychopharmacology

6.            Contribute to the design of preclinical and clinical neuropsychopharmacology studies

 

Titles of lectures and names of lecturers

A/A

Neuropsychopharmacology

Lecturer

1

Introduction and assignments

Christina Dalla, Stella Vlachou

2

Drug design/discovery

Dimitrios Vassilatis

3

Pharmacokinetics/Pharmacodynamics

Nikos Kokras

4

Neuroimaging ligands

Ioannis Pirmettis

5

Treatment of Neurodegenerative disorders (PD) and new targets

Neny Pervanidou

6

Neurodevelopmental disorders (ADHD, autism etc) and treatment

Leonidas Stefanis

7

The use of novel analytical techniques in medical research and drug discovery

Antonis Tsarbopoulos

8

Pharmacokinetics/Pharmacodynamics

Nikos Kokras

9

Antiepileptics

Christina Dalla, Marinos Sotiropoulos

10

Treatment of Neurodegenerative disorders (MS) and new targets

Harris Alexopoulos

11

Neuropsycho-pharmacogenomics

Dimitris Dikaios

12

Treatment of Neurodegenerative disorders (AD) and new targets

Ioannis Sotiropoulos

13

Neurobiology of Addiction, Alcohol

Foteini Delli

14

CNS Stimulants, Cannabis

Katerina Antoniou and Alexia Polissidis

15

Addiction and Nicotine

Stella Vlachou

16

Opioids and Psychedelics

Alexia Polissidis

17

Antipsychotics and lithium

Nikos Kokras

18

Anxiolytics and Antidepressants

Nikos Kokras, Christina Dalla

19

Pharmacoepidemiology

Giota Touloumi

20

Basics in clinical research

Eirini Griva